scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0272-6386(03)00653-X |
P698 | PubMed publication ID | 12900810 |
P50 | author | Jonathan Himmelfarb | Q96952610 |
P2093 | author name string | T Alp Ikizler | |
Jason Morrow | |||
Ellen McMonagle | |||
Jane Conner Kane | |||
Lara Pupim | |||
Michael Danielski | |||
P2860 | cites work | Serum albumin is a strong predictor of death in chronic dialysis patients | Q72889568 |
Plasma protein thiol oxidation and carbonyl formation in chronic renal failure | Q73293282 | ||
Protein Carbonyl Measurement by a Sensitive ELISA Method | Q73492231 | ||
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment | Q74667354 | ||
Oxidative stress in chronic renal failure | Q77226354 | ||
Protein carbonyl measurement by enzyme-linked immunosorbent assay | Q77907840 | ||
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients | Q78163875 | ||
Tissue sulfhydryl groups | Q26778486 | ||
The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis | Q28262364 | ||
Acute-phase proteins and other systemic responses to inflammation | Q28296941 | ||
A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. | Q29035699 | ||
Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment | Q31832598 | ||
The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation | Q33538228 | ||
An overview of haemodialysis and oxidant stress | Q33712875 | ||
Pathophysiology of the oxidative stress and its implication in uremia and dialysis | Q33813873 | ||
Premature cardiovascular disease in chronic renal failure | Q34017119 | ||
Inflammatory and atherosclerotic interactions in the depleted uremic patient. | Q34103513 | ||
Manifestations of oxidant stress in uremia | Q34126475 | ||
End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? | Q34135826 | ||
Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress | Q34658022 | ||
The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia | Q34952514 | ||
Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients | Q37872572 | ||
Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity | Q37872599 | ||
The antioxidants of human extracellular fluids | Q37931818 | ||
Albumin--an important extracellular antioxidant? | Q39628687 | ||
Malnutrition: a frequent misdiagnosis for hemodialysis patients | Q39735985 | ||
C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients | Q41721897 | ||
The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group | Q41745818 | ||
Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene | Q41853993 | ||
Elevated plasma F2-isoprostanes in patients on long-term hemodialysis | Q43586164 | ||
Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients | Q43651256 | ||
Albumin is the major plasma protein target of oxidant stress in uremia | Q43651261 | ||
Oxidant stress in nephrotic syndrome: comparison of F(2)-isoprostanes and plasma antioxidant potential | Q43690501 | ||
Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia | Q43795995 | ||
A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients | Q43812630 | ||
Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. | Q45978116 | ||
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. | Q46405188 | ||
A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients. | Q51567188 | ||
Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6 | Q58681737 | ||
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure | Q59306999 | ||
Antioxidant Potential of Anaerobic Human Plasma: Role of Serum Albumin and Thiols as Scavengers of Carbon Radicals | Q62665622 | ||
Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities | Q68771667 | ||
Detection of oxidants in uremic plasma by electron spin resonance spectroscopy | Q71754537 | ||
Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay | Q72461839 | ||
P433 | issue | 2 | |
P921 | main subject | hemodialysis patient | Q126109077 |
P304 | page(s) | 286-294 | |
P577 | publication date | 2003-08-01 | |
P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
P1476 | title | Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy | |
P478 | volume | 42 |
Q37015307 | Accelerated progression of arterial stiffness in dialysis patients compared with the general population |
Q79298194 | Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein-dependency of mediator induction |
Q41997271 | Aging and death-associated changes in serum albumin variability over the course of chronic hemodialysis treatment. |
Q37354661 | Antiatherogenic effects of vitamin E: the search for the Holy Grail |
Q34541172 | Association of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients |
Q37540154 | Associations of GSTM1*0 and GSTA1*A genotypes with the risk of cardiovascular death among hemodialyses patients |
Q37790669 | Carbamylated LDL |
Q36831489 | Clinical outcomes of peritoneal dialysis patients transferred from hemodialysis: a matched case-control study |
Q41068590 | Decreased number of CD14+TLR4+ monocytes and their impaired cytokine responses to lipopolysaccharide in patients with chronic kidney disease |
Q58842383 | Diet Modulates Adipose Tissue Oxidative Stress in a Murine Acute Chagas Model |
Q37421911 | Diets and enteral supplements for improving outcomes in chronic kidney disease |
Q45165519 | Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress |
Q34535945 | Electrolyzed-reduced water reduced hemodialysis-induced erythrocyte impairment in end-stage renal disease patients |
Q79442826 | Exercise improves albumin fractional synthetic rate in chronic hemodialysis patients |
Q37086653 | GST M1 polymorphism associates with DNA oxidative damage and mortality among hemodialysis patients. |
Q46568749 | High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis |
Q49852992 | Hypoalbuminaemia as a marker of trans-capillary leakage in community-acquired bacteraemia patients. |
Q36380598 | In-vivo oxidized albumin- a pro-inflammatory agent in hypoalbuminemia |
Q34978985 | Increasing high-sensitive C-reactive protein level predicts peritonitis risk in chronic peritoneal dialysis patients |
Q36785177 | Let them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients |
Q41167018 | Lipoprotein (a) as an acute phase reactant in patients on chronic hemodialysis |
Q90626498 | Longitudinal trajectory patterns of plasma albumin and C-reactive protein levels around diagnosis, relapse, bacteraemia, and death of acute myeloid leukaemia patients |
Q33880185 | Nutritional and anti-inflammatory interventions in chronic heart failure |
Q36538869 | Oxidative Stress Biomarkers and Left Ventricular Hypertrophy in Children with Chronic Kidney Disease |
Q43375953 | Oxidative Stress in Hemodialysis Patients: A Review of the Literature. |
Q37600685 | Plasma protein-bound di-tyrosines as biomarkers of oxidative stress in end stage renal disease patients on maintenance haemodialysis |
Q36050489 | Potential Role of Vegetarianism on Nutritional and Cardiovascular Status in Taiwanese Dialysis Patients: A Case-Control Study |
Q36344799 | Prevalence and risk factors associated with peripheral artery disease in elderly patients undergoing peritoneal dialysis |
Q37604744 | Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial |
Q37004026 | Relationship between serum albumin and pulse wave velocity in patients on continuous ambulatory peritoneal dialysis |
Q36682420 | Risk Factors for New-Onset Cardiac Valve Calcification in Patients on Maintenance Peritoneal Dialysis |
Q34462607 | Risk factors associated with brachial-ankle pulse wave velocity among peritoneal dialysis patients in Macao |
Q37207365 | Serum Concentrations of F2-Isoprostanes and 4-Hydroxynonenal in Hemodialysis Patients in Relation to Inflammation and Renal Anemia |
Q40123974 | Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients |
Q37634609 | Serum albumin levels and their correlates among individuals with motor disorders at five institutions in Japan |
Q34907338 | Serum oxidized albumin and cardiovascular mortality in normoalbuminemic hemodialysis patients: a cohort study |
Q42427842 | The effect of N-acetylcysteine on oxidative serum biomarkers of hemodialysis patients |
Q37205499 | Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study |
Q36084415 | Unexpected Normal Colloid Osmotic Pressure in Clinical States with Low Serum Albumin |
Search more.